Commission Regulation (EC) No 500/2007 of 7 May 2007 amending Regulation (EC) No 1463/2004 as regards the introduction of a maximum residue limit for the feed additive Sacox 120 microGranulate , belonging to the group of coccidiostats and other medicinal substances (Text with EEA relevance)

8.5.2007 EN Official Journal of the European Union L 118/3
COMMISSION REGULATION (EC) No 500/2007
of 7 May 2007
amending Regulation (EC) No 1463/2004 as regards the introduction of a maximum residue limit for the feed additive ‘Sacox 120 microGranulate’, belonging to the group of coccidiostats and other medicinal substances
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 13(3) thereof,
Whereas:
(1) The additive salinomycin sodium (Sacox 120 microGranulate) was authorised under certain conditions in accordance with Council Directive 70/524/EEC (2). Commission Regulation (EC) No 1463/2004 (3) authorised that additive for 10 years for use for chickens for fattening, linking the authorisation to the person responsible for putting that additive into circulation. That additive was notified as an existing product on the basis of Article 10 of Regulation (EC) No 1831/2003. Since all the information required under that provision was submitted, that additive was entered into the Community Register of Feed Additives.
(2) Regulation (EC) No 1831/2003 provides for the possibility of modifying the authorisation of an additive further to a request from the holder of the authorisation and an opinion of the European Food Safety Authority (the Authority). The holder of the authorisation of the additive salinomycin sodium (Sacox 120 microGranulate) has submitted an application which proposes changing the conditions of the authorisation by introducing a maximum residue limit (MRL) as evaluated by the Authority.
(3) In its opinion adopted on 30 June 2004 (4), the Authority proposed to establish an MRL of 5 μg/kg for the active substance concerned. It may be necessary to review that MRL in the light of the results of a future evaluation of that active substance by the European Agency for the Evaluation of Medicinal Products.
(4) Regulation (EC) No 1463/2004 should therefore be amended accordingly.
(5) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,